DK3412684T3 - Nye selektionsvektorer og fremgangsmåder til selektering af eukaryotiske værtsceller - Google Patents

Nye selektionsvektorer og fremgangsmåder til selektering af eukaryotiske værtsceller Download PDF

Info

Publication number
DK3412684T3
DK3412684T3 DK18179678.0T DK18179678T DK3412684T3 DK 3412684 T3 DK3412684 T3 DK 3412684T3 DK 18179678 T DK18179678 T DK 18179678T DK 3412684 T3 DK3412684 T3 DK 3412684T3
Authority
DK
Denmark
Prior art keywords
methods
host cells
eukaryotic host
new selection
selection vectors
Prior art date
Application number
DK18179678.0T
Other languages
Danish (da)
English (en)
Inventor
Yehuda G Assaraf
Thomas Jostock
Hans-Peter Knopf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK3412684T3 publication Critical patent/DK3412684T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/69Increasing the copy number of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/40Systems of functionally co-operating vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK18179678.0T 2013-07-31 2014-07-29 Nye selektionsvektorer og fremgangsmåder til selektering af eukaryotiske værtsceller DK3412684T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361860439P 2013-07-31 2013-07-31
EP14753158.6A EP3027646B1 (en) 2013-07-31 2014-07-29 Novel selection vectors and methods of selecting eukaryotic host cells

Publications (1)

Publication Number Publication Date
DK3412684T3 true DK3412684T3 (da) 2022-07-04

Family

ID=51383909

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18179678.0T DK3412684T3 (da) 2013-07-31 2014-07-29 Nye selektionsvektorer og fremgangsmåder til selektering af eukaryotiske værtsceller
DK14753158.6T DK3027646T3 (en) 2013-07-31 2014-07-29 New selection vectors and methods for selecting eukaryotic host cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14753158.6T DK3027646T3 (en) 2013-07-31 2014-07-29 New selection vectors and methods for selecting eukaryotic host cells

Country Status (19)

Country Link
US (1) US11807855B2 (enExample)
EP (3) EP4095153A1 (enExample)
JP (1) JP6576924B2 (enExample)
KR (1) KR102288233B1 (enExample)
CN (2) CN105593239B (enExample)
AU (1) AU2014297966B2 (enExample)
BR (1) BR112016001182A2 (enExample)
CA (1) CA2918117C (enExample)
DK (2) DK3412684T3 (enExample)
ES (2) ES2689136T3 (enExample)
HU (1) HUE058885T2 (enExample)
IL (1) IL243352B (enExample)
LT (2) LT3027646T (enExample)
MX (1) MX369109B (enExample)
PL (2) PL3412684T3 (enExample)
PT (2) PT3027646T (enExample)
RU (1) RU2716977C2 (enExample)
SG (1) SG11201510625TA (enExample)
WO (1) WO2015015419A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2401377T3 (en) 2009-02-27 2016-08-29 Novartis Ag Expression vector system comprising two selection markers
PT3027646T (pt) 2013-07-31 2018-10-16 Novartis Ag Novos vetores e métodos de seleção de células hospedeiras eucarióticas
IL258538B2 (en) * 2015-10-09 2023-04-01 Genzyme Corp Early isolation after the infection of cells (epic) for the production of biological material
EP3521435A1 (en) 2018-02-06 2019-08-07 Bayer AG A high stringency selection system for protein expression in proline-auxotrophic cells
US20210356377A1 (en) * 2018-09-07 2021-11-18 Medimmune, Llc Methods Of Cell Selection
MX2022003192A (es) 2019-09-18 2022-04-11 Novartis Ag Proteinas de fusion nkg2d y sus usos.
JP2023550459A (ja) 2020-11-23 2023-12-01 ノバルティス アーゲー 抗体構築物の発現技術
JP2024517711A (ja) 2021-04-29 2024-04-23 ノバルティス アーゲー 高シアル酸付加細胞
CN118510902A (zh) * 2021-12-21 2024-08-16 Absci公司 用于鉴定具有增加的可溶性靶蛋白表达的菌株的FolA选择测定

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771036A (en) 1986-02-10 1988-09-13 Trustees Of Columbia University In The City Of New York Method and ophthalmic composition for the prevention and reversal of cataracts
JP2585532B2 (ja) 1986-05-10 1997-02-26 三井東圧化学株式会社 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてt−PAを生産する方法
EP0557459B1 (en) 1990-11-13 1997-10-22 Immunex Corporation Bifunctional selectable fusion genes
JP3438889B2 (ja) 1991-03-29 2003-08-18 ジェネンテク,インコーポレイテッド 所望のタンパク質を高レベルに発現させる組換え宿主細胞の選別法
WO1994028143A1 (en) 1993-05-21 1994-12-08 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5830698A (en) 1997-03-14 1998-11-03 Idec Pharmaceuticals Corporation Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
US6106825A (en) 1997-05-07 2000-08-22 University Of Florida Entomopoxvirus-vertebrate gene delivery vector and method
FR2784030B1 (fr) 1998-10-02 2002-12-20 Inst Nat Sante Rech Med Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
DE10256083A1 (de) 2002-11-29 2004-08-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
US7384744B2 (en) 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
BRPI0408246A (pt) 2003-03-11 2006-03-01 Applied Research Systems vetores de expressão que compreendem o promotor ie2 do mcmv
US20070224635A1 (en) 2004-01-30 2007-09-27 Maxygen Holdings, Ltd. Regulated Stop Codon Readthrough
US20060275794A1 (en) 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
CN101389763B (zh) 2006-02-21 2013-01-23 科罗迈吉尼科斯公司 高水平表达蛋白质的宿主细胞的选择
BRPI0712073B8 (pt) 2006-05-17 2021-05-25 Hoffmann La Roche ácido nucléico para produção de um polipeptídio ou proteína heteróloga
PL2227549T3 (pl) * 2007-12-21 2015-12-31 Novartis Ag System selekcji do hodowli komórek eukariotycznych oparty na genie związanego z błoną receptora folianowego
ES2784926T3 (es) 2007-12-21 2020-10-02 Novartis Ag Vector de expresión de mamífero
RU2528858C2 (ru) 2008-08-28 2014-09-20 Новартис Аг Дисплей на поверхности клеток полипептидных изоформ на основе прочитывания терминирующего кодона
WO2010029130A1 (en) 2008-09-10 2010-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Neuronal viability factor and use thereof
SG173457A1 (en) 2009-02-27 2011-09-29 Novartis Ag Methods for selecting eukaryotic cells expressing a heterologous protein
DK2401377T3 (en) 2009-02-27 2016-08-29 Novartis Ag Expression vector system comprising two selection markers
CN102030754B (zh) * 2009-09-28 2013-07-10 中国科学院微生物研究所 非病毒载体及其制备方法与应用
PT3027646T (pt) 2013-07-31 2018-10-16 Novartis Ag Novos vetores e métodos de seleção de células hospedeiras eucarióticas

Also Published As

Publication number Publication date
US20160177318A1 (en) 2016-06-23
EP3027646A1 (en) 2016-06-08
JP6576924B2 (ja) 2019-09-18
EP3412684A1 (en) 2018-12-12
PL3412684T3 (pl) 2022-08-08
AU2014297966A1 (en) 2016-01-28
RU2016106270A3 (enExample) 2018-04-27
CN105593239B (zh) 2020-10-16
AU2014297966B2 (en) 2017-10-26
US11807855B2 (en) 2023-11-07
EP3412684B1 (en) 2022-04-06
KR102288233B1 (ko) 2021-08-10
CN112029791A (zh) 2020-12-04
SG11201510625TA (en) 2016-02-26
RU2716977C2 (ru) 2020-03-17
KR20160030524A (ko) 2016-03-18
MX2016001396A (es) 2016-05-05
HUE058885T2 (hu) 2022-09-28
CA2918117A1 (en) 2015-02-05
IL243352A0 (en) 2016-03-31
MX369109B (es) 2019-10-29
IL243352B (en) 2018-06-28
PT3412684T (pt) 2022-06-27
LT3412684T (lt) 2022-07-11
PL3027646T3 (pl) 2019-03-29
CA2918117C (en) 2023-01-24
ES2920510T3 (es) 2022-08-04
RU2016106270A (ru) 2017-08-31
LT3027646T (lt) 2018-09-25
BR112016001182A2 (pt) 2017-08-29
ES2689136T3 (es) 2018-11-08
DK3027646T3 (en) 2018-09-24
EP4095153A1 (en) 2022-11-30
WO2015015419A1 (en) 2015-02-05
CN105593239A (zh) 2016-05-18
EP3027646B1 (en) 2018-06-27
JP2016525366A (ja) 2016-08-25
PT3027646T (pt) 2018-10-16

Similar Documents

Publication Publication Date Title
DK3412684T3 (da) Nye selektionsvektorer og fremgangsmåder til selektering af eukaryotiske værtsceller
DK3192869T3 (da) Isoleret oligonukleotid og anvendelse deraf i nukleinsyresekvensering
HUE046262T2 (hu) Sejt
DK3597742T3 (da) Car-udtrykkende vektor og car-udtrykkende t-celler
DK2943511T3 (da) Nye heterodimeriske proteiner
DK3230044T3 (da) Transplantationsstøttestruktur til bruskreparation og fremgangsmåde til fremstilling af denne
DK3047013T3 (da) Fremgangsmåder og systemer til forarbejdning af en cellekultur
DK3087095T3 (da) FcRn-antagonist og fremgangsmåder til anvendelse
HUE053101T2 (hu) Javított T-sejt-készítmények
DK2997132T3 (da) Fremgangsmåder til konstruering af allogenisk og høj-aktiv T-celle til immunoterapi
DK3198035T3 (da) Fremgangsmåder til forudsigelse af medicinrespons
DK2978419T3 (da) Sammensætninger til forbedring af cellelevedygtighed og fremgangsmåder til anvendelse deraf
DK2999103T3 (da) Konverter og fremgangsmåde til styring deraf
DK3540429T3 (da) Indretning og fremgangsmåder til anvendelse af indretning til detektion af hyperammoniæmi
DK3536804T3 (da) Mikropeptider og anvendelse deraf til modulering af genekspression
DK3227435T3 (da) Gammadelta-t-celleekspansionsprocedure
DK2970843T3 (da) Fremgangsmåder til frembringelse af cellebank med høj densitet
DK3087371T3 (da) Fremgangsmåde til klassificering af frø
DK2979743T3 (da) Anordning og fremgangsmåde til lagring og fordeling af vedvarende energi
DK3080302T3 (da) Metoder og sonder til identifikation af genalleler
DK3083676T3 (da) Hidtil ukendte eukaryote celler og fremgangsmåder til rekombinant ekspression af et produkt af interesse
EP3066193C0 (en) CELL CULTURE PROCESS
DK3265555T3 (da) T-celle-ekspansion
DK3131577T3 (da) Modificerede værtsceller og anvendelser deraf
DK3321501T3 (da) System til energilagring og -genvinding